Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CleanTech successfully produces 99.78pc-pure lithium carbonate

(Sharecast News) - CleanTech Lithium announced the successful production of lithium carbonate with 99.78% purity from its pilot plant downstream process on Tuesday, exceeding the 99.6% benchmark for battery-grade lithium carbonate. The AIM-traded firm said the milestone, achieved through a collaboration with Conductive Energy in Chicago, demonstrated the scalability and efficiency of its process design, which aimed to minimise steps while consistently delivering high-quality outputs.

Key processing steps included forward osmosis (iFO) to concentrate the eluate, contaminant removal, carbonation to technical-grade lithium carbonate, and post-carbonation polishing to achieve battery-grade standards.

The pilot plant, located in Copiapó, Chile, faced temporary disruptions due to freezing weather in Chicago, which paused iFO operations.

However, the process continued using pre-carbonation solution produced before the weather-related pause, resulting in an eight kilogram batch of high-grade lithium carbonate.

Contaminant reduction was a notable success, with problematic elements such as calcium, magnesium, and boron reportedly reduced by 98.5%, 99.9%, and over 99.99%, respectively.

Further upgrades to the process, including the addition of nanofiltration for enhanced purification, were underway during the operational pause.

The board said the refinements aimed to improve efficiency and automation, ensuring reliable production of battery-grade lithium carbonate at scale.

In a separate development, CleanTech also announced its voluntary delisting from the US OTCQX market due to low trading volumes and associated administrative costs.

The company's shares remained listed on the AIM market in London, the Frankfurt Stock Exchange, and the US OTC Pink Market.

"We are pleased to report the production of high grade lithium carbonate with a purity of 99.78% from an initial batch of concentrated eluate from our Laguna Verde project," said executive chairman Steve Kesler.

"This phase of work has focused on fine-tuning the process and preparing to scale up pilot plant output.

"Our collaborative efforts with Conductive Energy and Forward Water on the downstream process are advancing our aim to produce significant quantities of battery grade product to introduce to potential strategic partners and off-takers."

At 1330 GMT, shares in CleanTech Lithium were up 1.67% at 15.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hunting reports higher margins, full-year earnings
(Sharecast News) - Hunting reported higher earnings and margins for 2025 on Thursday despite a modest decline in revenue, as the precision engineering group benefited from improved operational performance and continued to expand shareholder returns under its long-term growth strategy.
Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.